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Dear Editor, 
We evaluated the cumulative incidence of mental retardation in patients with 
hereditary retinoblastoma. Records of the national Dutch retinoblastoma 
register were used. This register is complete from 1945 through 1994. Coop- 
eration of the hereditary retinoblastoma patients or their parents was soli- 
cited by a letter from the ophthalmologist. The patients with hereditary 
retinoblastoma born between 1945 and 1970 were visited at home in 1985.’ 
On that occasion, information on mental retardation was collected. In addi- 
tion, questionnaires were sent in 1993 to the patients’ parents or caregivers to 
obtain up-to-date information regarding the patient’s condition, visual acui- 
ty, and second primary tumors. 
Parents of the hereditary retinoblastoma patients born between 1971 and 
1994 were visited at home.2 Information was obtained on the possible causes 
of the mental retardation: brain damage or fetal, perinatal, or postnatal 
disorders (infection, trauma, medication, or anoxia). The reported disorders 
were verified and the data regarding karyotyping and D N A  analyses, if avail- 
able, were traced by a letter to the general physician. Information regarding 
the visual acuity, if available, was obtained from the ophthalmic surgeon. 
Since the measurement of the intelligence quotient of mentally and visually 
handicapped persons is complicated and not often valid,’ this parameter can- 
not be used to define mentally handicapped retinoblastoma patients. There- 
fore, the following criteria for mental retardation were used: the necessity of 
residential treatment for mental retardation or home care with day treatment 
and special education. These criteria only define severely and modcrately 
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BiUuni Sex RB 
(months) 
Treatment 
(OD/  0s) 
Bil 
Bil 
Bil 
Bil 
Bil 
Bil 
Bil 
Bil 
Bil 
Bil 
Bil 
Bil 
Bil 
Uni 
Bil 
Bil 
Bil 
Bil 
Bil 
Bil 
Bil 
F 
F 
M 
M 
M 
M 
M 
M 
M 
F 
F 
M 
M 
F 
F 
M 
F 
M 
M 
M 
F 
4 
3 
21 
2 
12 
6 
18 
10 
2 
2 
2 
24 
4 
8 
2 
6 
5 
16 
2 
2 
I 1  
E/E 
E / E  
E/E 
E/E 
E / X  
E/XLCX 
EIX 
XC/E 
EIE 
XCIE 
EIXE 
XEIE 
E/E 
/ E  
E / X  
XCE/E 
E/XE 
EICE 
x / x  
X / X E  
E/XE 
Status 
Alive 
Alive 
Dead 
Alive 
Dead 
Alive 
Alive 
Alive 
Alive 
Alive 
Alive 
Alive 
Alive 
Alive 
Alive 
Alive 
Alive 
Alive 
Alive 
Dead 
Alive 
Visus 
50 
48 
23 
44 
I 
36 
34 
33 
32 
29 
29 
26 
26 
24 
21 
I 9  
19 
18 
‘ 3  
3 
3 
Blind 
Blind 
Blind 
Blind 
Impaired 
Blind 
Impaired 
Normal 
Blind 
Impaired 
Blind 
Blind 
Blind 
Normal 
Impaired 
Blind 
Blind 
Blind 
Impaired 
Impaired 
Blind 
Chrom/DNa analysis 
~~ ~~ 
Not performed 
Trisomy 2 I ,  no I 39 deletion 
Not performed 
Not performed 
Not performed 
I 39 deletion 
Not performed 
Not performed 
No chromosomal abnormality 
Not performed 
13914-31 deletion 
Not performed 
Not  performed 
I 3 / X  translocation 
I 39 14-22 deletion 
XXXXY syndrome, no I 39 deletion 
Not performed 
Not performed 
I 391 3.2-14.2 deletion 
13913-31 deletion 
Trisomy 2 I ,  no I 39 deletion 
M idja ce 
abnormalities 
~~ ~~ 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Bil, bilateral; uni, unilateral; RB, age in months at  diagnosis retinoblastoma; OD, right eye; OS, left eye; E, enucleation; 
x, radiation; L, light coagulation; C, chemotherapy; chrom/DNA, chromosomal or D N A  analysis; age, age in 1995 or a t  death. 
T A B L E  I .  Hereditary retinoblastoma 
patients with mental retardation from 
the Dutch retinoblastoma register 
(n=241). 
mentally handicapped children. Retinoblastoma was considered as heredi- 
tary in cases of bilaterality, family history of retinoblastoma, or a germinal 
defect in the R B  I gene. 
This project was approved by the Medical Ethics Committee of the Free 
University Hospital, Amsterdam, The Netherlands. 
Mental retardation Twenty-one mentally retarded patients were identi- 
fied among 241 hereditary retinoblastoma patients (8.7%) born in the period 
1945-1994 (Table I). One patient had the unilateral form and a 13/X translo- 
cation and was consequently classified as hereditary. It is noteworthy that 
none of the mentally retarded patients had a positive family history of retino- 
blastoma. 
Results of karyotyping and/or D N A  analyses were available for ten of these 
21 patients. Chromosomal or D N A  analysis was not performed in the 1 1  
‘older’ cases. All but one of the ten available analyses were abnormal: 139 de- 
letion was found in five patients, trisomy 21 (without 13q deletion) in two, 
13/X translocation in one, and a XXXXY-Klinefelter syndrome (without 134 
deletion) in one. Only in one case was rubella during pregnancy documented. 
No other fetal, perinatal, or postnatal problems were recorded. Neither 
parents nor physicians reported any accident, event, or reason why the pa- 
tients should have mental retardation. Therefore, it is likely that in most, if 
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not in all, of the cases mental retardation is related to the observed extensive 
chromosomal abnormalities that probably also led to retinoblastoma. These 
abnormalities were not inherited from the parents. 
The typical 139 deletion facial appearance described by Motegi et al.4 was 
found in eight of the 21 patients: prominent eyebrows, broad nasal bridge, 
bulbous tip of the nose, a large mouth with a thin upper lip, and a long phil- 
trum (Table I).  Six of these eight patients had a 134 deletion; no 139 deletion 
was detectable with karyotyping in one patient and one patient was not 
tested. 
Fifteen patients lived in an institution for visually and mentally handi- 
capped patients, three lived at home with their parents, and three were de- 
ceased (14.2%)~ all due to pneumonia. Two patients had normal vision (90/0), 
six had impaired vision (28'X1),  and 13 were blind (63%) - 12 due to bilateral 
enucleation. No second primary tumors were found in the 21 mentally re- 
tarded retinoblastoma patients. 
Discussion and conclusions We stress that we have obtained our re- 
sults from the complete national register; this excludes ascertainment biases. 
We found a high cumulative incidence of mental retardation (8.7%) in heredi- 
tary retinoblastoma patients. The cumulative incidence of severe and moder- 
ate mental retardation in the general population in The Netherlands is about 
0 . 4 % ~ ~  Thus, the relative risk for mental retardation is about 20 in hereditary 
retinoblastoma patients. This could even be an underestimation as only the 
severely and moderately mentally retarded retinoblastoma patients were con- 
sidered. 
The cause of mental retardation in our patient group could not be related 
to any special event during pregnancy, except for one rubella infection. All 
other pregnancies and perinatal and postnatal periods were uneventful. We 
do not consider irradiation therapy to be a cause of mental retardation, as 
analysis of the data inTable I and data on the number of irradiated and non- 
irradiated patients shows that 7.5% (13 out of 173) of the irradiated patients 
and 12% (8 out of 68) of the non-irradiated group were mentally retarded. 
Therefore, it is likely that the association between hereditary retinoblastoma 
and mental retardation is a specific genetic abnormality. 
We did not find any familial mental retardation among the retinoblastoma 
patients. This was also reported byTarkkanea6 
Our findings confirm those of Motegi et regarding the special appear- 
ance of the midface of patients with the 134 deletion. Mostly, these midfacial 
abnormalities were already detected before irradiation therapy and they were 
outside the radiation field and different from the late effects of external beam 
irradiation therapy described by Imhof et al.' 
In conclusion, one can find patients with retinoblastoma, mental retarda- 
tion, and midfacial abnormalities (Motegi syndrome). These three phenom- 
ena seem to be due to quite extensive chromosomal aberrations. These defects 
must be new, as none of the eight patients with this triad of abnormalities had 
a family history of retinoblastoma. 
The Motegi syndrome is very rare, although it is frequently found in retino- 
blastoma patients. This implies that a child with Motegi syndrome must be 
examined for retinoblastoma. 
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